US Endovascular, founded in 2014, is a Midwest-based medical device company focused on meeting the evolving needs of healthcare providers. With over 70 years of combined experience, our team is committed to transforming the traditional device-provider relationship to drive down costs.
We deliver next-generation, clinically-relevant devices directly from manufacturers to end users, economic buyers, and corporate partners, cutting out unnecessary steps and reducing expenses.
US Endovascular's streamlined sales and marketing strategy allows us to quickly capture market share in today's complex healthcare environment. With healthcare consolidation and the increasing demand for high quality at lower costs, our low-overhead distribution model is well-aligned with industry needs. By building strong relationships with large healthcare providers, aligning with complementary device companies, and partnering with a world-class logistics organization, we maximize efficiency and optimize value.
Our growing portfolio of high-quality products, including stents, angioplasty balloons, and other next-generation technology, uniquely positions us to deliver line-by-line savings and bundle offerings that outpace competitors. Our dedicated clinical support and product implementation teams are integral to this strategy.
Leveraging deep industry expertise and robust sales channels, US Endovascular is positioned to elevate distribution efficiency and set new standards across the industry.